Sodium–Glucose Cotransporter 2 Inhibitor Combined with Conventional Diuretics Ameliorate Body Fluid Retention without Excessive Plasma Volume Reduction
Maki Asakura-Kinoshita(Jichi Medical University), Daisuke Nagata(Jichi Medical University), Marina Miura, Yasuharu Miyazawa(Sapporo Minami Hospital), Takahiro Masuda(Jichi Medical University), Tetsu Akimoto(Jichi Medical University), Masato Morinari(Stony Brook School), Kazuyuki Shimada(Yamato Municipal Hospital), Kentaro Oka(Jichi Medical University), Ken Ohara(Jichi Medical University), Kyohei Misawa(Jichi Medical University)
Cited by 14
Related Papers
Morning Surge in Blood Pressure as a Predictor of Silent and Clinical Cerebrovascular Disease in Elderly Hypertensives
|Circulation|2003|1.2k
SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice
|American Journal of Physiology-Renal Physiology|2013|481
Increase in SGLT1-mediated transport explains renal glucose reabsorption during genetic and pharmacological SGLT2 inhibition in euglycemia
|American Journal of Physiology-Renal Physiology|2013|308
Periadventitial Adipose Tissue Plays a Critical Role in Vascular Remodeling
|Circulation Research|2009|211
Natriuretic effect by exendin-4, but not the DPP-4 inhibitor alogliptin, is mediated via the GLP-1 receptor and preserved in obese type 2 diabetic mice
|American Journal of Physiology-Renal Physiology|2012|158